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Introduction
Recent insights in sepsis pathology have led to the view
that not the initial hyperinflammatory state, but rather a
profoundly suppressed state of the immune system, also
called immunoparalysis, accounts for the majority of
sepsis-related deaths. Therefore, reconstitution of immu-
nocompetence in sepsis is emerging as a promising ther-
apeutic target to improve outcome. Bacille Calmette-
Guérin (BCG) vaccine not only protects against tubercu-
losis, but exerts beneficial effects on other infectious dis-
eases as well. These non-specific effects of BCG seem to
be mediated by potentiation of adaptive immunity
through heterologous effects, as well as epigenetic func-
tional reprogramming of innate immune cells to an
enhanced phenotype, a process described as ‘trained
immunity’, which has been shown in vitro, ex vivo, and
in animal models. Therefore, BCG-vaccination could
represent a novel therapeutic option to treat sepsis-
induced immunoparalysis, although its immunomodula-
tory effects in humans in vivo have not yet been investi-
gated. Furthermore, the live BCG vaccine presents a
potential risk of disseminated disease in immunopara-
lyzed patients, which can be circumvented by inactivat-
ing the vaccine through gamma-irradiation.
Objectives
To determine the effects of gamma-irradiated BCG-vac-
cination on the in vivo innate immune responses
induced by human endotoxemia. Also, to determine the
effects of gamma-irradiated BCG-vaccination on ex vivo
responsiveness of leukocytes to various inflammatory
stimuli.
Methods
In a randomized double blind placebo-controlled study,
healthy male volunteers were vaccinated with gamma-
irradiated BCG (n = 10) or placebo (n = 10) and
received 1 ng/kg lipopolysaccharide (LPS) intravenously
on day 5 after vaccination to assess the in vivo immune
response. Peripheral blood mononuclear cells were sti-
mulated with various related and unrelated pathogens 5,
8 to 10, and 25 to 35 days after vaccination to assess ex
vivo immune responses.
Results
LPS administration elicited a profound systemic immune
response, characterized by increased levels of pro-and
anti-inflammatory cytokines, hemodynamic changes, and
flu-like symptoms. However, BCG neither modulated
this in vivo immune response (Figure 1), nor ex vivo leu-
kocyte responses at any time-point (Figure 2).
Conclusions
Gamma-irradiated BCG does not modulate the innate
immune response in vivo in humans and is therefore
unlikely to represent an effective treatment option to
restore immunocompetence in patients with sepsis-
induced immunoparalysis.
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Figure 1 In the panels A and B, median values of pro-inflammatory cytokines TNF-a and Il-6 are depicted while in panel C median values of the
anti-inflammatory cytokine IL-10 is shown (n = 10 per group). Panels D-F depict median ± interquartile range of area under curve (AUC) of the
respective cytokines (n = 10 per group). P values calculated using Mann-Whitney U-tests.
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Figure 2 Data expressed as median and interquartile range of the fold change compared with day 1 (before vaccination) (n = 10 per group). p-
values calculated using repeated measures two-way analysis of variance (ANOVA, time and interaction terms) on log transformed data. Day 6
was the endotoxemia experiment day.
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